Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-020471-23Phase 3Completed
Phase 3, open-label, single-arm trial of oxycodone in pain and cancer pain, sponsored by Purdue Pharma. Primary endpoint: Safety analysis. Started Aug 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-020471-23.